Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Disclosed deployed
—
across known amounts
Stages
—
About
Cormorant Asset Management is a specialized investment firm focused on healthcare and life sciences. It invests in innovative biotechnology, pharmaceutical, and healthcare technology companies across private and public markets. The firm leverages its expertise to back growth-stage businesses, particularly those driving advancements in medical treatments and healthcare solutions. Cormorant combines venture capital and hedge fund strategies to identify high-potential opportunities in the rapidly evolving life sciences sect
Portfolio
No portfolio companies in this dataset yet.
Investor Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Cormorant Asset Management's primary investment focus?
- Cormorant Asset Management is a specialized investment firm focused on healthcare and life sciences, investing in biotechnology, pharmaceutical, and healthcare technology companies.
- When was Cormorant Asset Management founded?
- Cormorant Asset Management was founded in 2013.
- What is the geographic location of Cormorant Asset Management's headquarters?
- Cormorant Asset Management is headquartered in Boston, United States.
- Can you name some notable companies in Cormorant Asset Management's portfolio?
- According to startupim data, notable companies in Cormorant Asset Management's portfolio include Chemomab Therapeutics and Fore Biotherapeutics.
- What is the typical investment range for Cormorant Asset Management?
- Cormorant Asset Management's investment range is between $31.5M and $75M per round.
- Has Cormorant Asset Management had any exits from its portfolio companies?
- Yes, Cormorant Asset Management had an exit in March 2021 with Chemomab Therapeutics, which underwent a Reverse Merger Event and was listed on NASDAQ.
- In which sectors does Cormorant Asset Management primarily invest?
- Cormorant Asset Management primarily invests in the Health Tech & Life Sciences sector, as indicated by its portfolio companies and investment rounds.
- What was Cormorant Asset Management's most recent investment activity?
- Cormorant Asset Management's most recent investment was in Fore Biotherapeutics in August 2023, amounting to $75,000,000.
- Has Cormorant Asset Management acted as a lead investor in any rounds?
- Yes, Cormorant Asset Management was a lead investor in a $45,500,000 round for Chemomab Therapeutics in March 2021.